Stories and Perspectives
FEATURED
Discover how Guardant is advancing the role of blood-based cancer screening tests and liquid biopsies in early cancer detection and precision oncology.
Top Stories
In the
News
Catch up on the latest headlines
and media coverage featuring us.
TIME | October 30, 2024
TIME’s Best Inventions of 2024: Shield Blood Test
The Washington Post | September 10, 2024
Opinion | Science Finds New Ways to Detect Cancer, but Politics Gets in the Way
CBS News | July 29, 2024
FDA Approves Blood Test for Colon Cancer Detection
Healthcare Innovation Group | July 16, 2024
It’s Time for a New Option in Colorectal Cancer Screening
STAT | July 9, 2024
Blood Tests for Cancer Patients Save Lives. Access Remains an Issue.
TIME | May 30, 2024
TIME100 Most Influential Companies 2024: Guardant Health
New York Times | May 23, 2024
F.D.A. Panel Endorses Safety of Colon-Cancer Blood Test
Fierce Biotech | May 13, 2024
Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test
Helmy Eltoukhy / Milken Institute | April 17, 2024
Leveling the Health Care Playing Field through Emerging Technology
PharmaTimes | April 3, 2024
Study Reveals New Liquid Biopsy Test Could Benefit Thousands of Lung Cancer Patients
Fast Company | March 19, 2024
Meet the Diagnostics Company Helping Find Cancer and Choose the Right Treatment
Colon Cancer Coalition | March 14, 2024
Q&A with Guardant Health about Blood Tests for CRC Screening
Check Out Our Newsroom
Get a front-page overview of Guardant's latest annoucements, news stories and resources.
Read More